Market Tracker

05/23 4:10pm ET

Altimmune Inc (NASDAQ:ALT)

0.5739
Delayed Data
As of 3:55pm ET
 +0.0654 / +12.86%
Today’s Change
0.41
Today|||52-Week Range
4.75
-71.16%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close0.51
Today’s open0.50
Day’s range0.43 - 0.66
Volume4,118,149
Average volume (3 months)448,920
Market cap$11.6M
Data as of 3:55pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-69.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+105.31%
P/E ratioNM
Price/Sales2.37
Price/Book0.24

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...-0.16-2.23%
NVIVInVivo Therapeutics ...-0.24-3.31%
HSGXHistogenics Corp+0.07+3.21%
AZRXAzurRx BioPharma Inc+0.03+1.10%
Data as of 3:54pm ET, 05/23/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$10.7M
Annual profit (last year)-$46.4M
Net profit margin-432.33%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
Chief Financial &
Accounting Officer
Will Brown
Corporate headquarters
Gaithersburg, Maryland

Forecasts